- Investigational New Drug application for non-small cell lung cancer trial with luvelta cleared by U.S. Food and Drug Administration; Phase 2 on track to begin dosing in the second half of 2024 -

HONOLULU, May 13, 2024 (GLOBE NEWSWIRE) -- Territorial Bancorp Inc. (NASDAQ:  TBNK) (the “Company”), headquartered in Honolulu, Hawaii, the holding company parent of Territorial Savings Bank, announces that its Board of Directors approved a quarterly cash dividend of $0.01 per share.  The dividend is expected to be paid on June 10, 2024 to stockholders of record as of May 28, 2024.

Earliest Seasonal Deployment Positions the Company for Record Growth

RAPID CITY, S.D., May 13, 2024 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) today announced the pricing of a registered public debt offering of $450 million aggregate principal amount of 6.00% senior unsecured notes due Jan. 15, 2035. The company expects the offering to close on May 16, 2024, subject to customary closing conditions.

VANCOUVER, British Columbia, May 13, 2024 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO), (Frankfurt: IJA2), (Munich: A2PU92) (the "Company") today announced that its Chairman of the Board, Bernard Lonis, will be taking a leave of absence due to health reasons. Mr. Lonis has been hospitalized this week following one planned and one unplanned surgery and will remain under medical care for an unspecified period.

IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial results for the first quarter ended March 29, 2024.

– On Track to Provide Topline Data from the Ongoing Pivotal Clinical Trial with Oxylanthanum Carbonate (OLC) in Q2 2024 –

BARTLETT, Tenn., May 13, 2024 (GLOBE NEWSWIRE) -- SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecom company focused on the underbanked and underserved, today announced its financial results for the first quarter ended March 31, 2024.

ATHENS, Greece, May 13, 2024 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (the “Company” or “OET”) (NYSE:ECO / OSE:OET), will report unaudited condensed results for the first quarter and three month period ended March 31, 2024, on Thursday, May 16, 2024, and a webcast/teleconference will be held at 13:30 CET.

Perrysburg, Ohio, May 13, 2024 (GLOBE NEWSWIRE) --  – O-I Glass, Inc. (“O-I Glass”, “O-I” or the “Company”) announced today that the Company has completed full allocation of the proceeds from its second round of Green Bond offerings to advance the company’s climate-change strategy. In May of 2023, Owens-Brockway Glass Container Inc., and OI European Group B.V. launched private Green Bond offerings of $690 million and €600 million, respectively.  

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET.

CINCINNATI, May 13, 2024 (GLOBE NEWSWIRE) -- Paycor HCM, Inc. (Nasdaq: PYCR) (“Paycor”), a leading provider of human capital management (HCM) software, today announced that management is scheduled to present at the following investor conferences.

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Lottery.com Inc. (Nasdaq: LTRY, LTRY), a leading technology company transforming how, where, and when lottery and sports media content is delivered, today announces a significant step to accelerate its global expansion efforts. Lottery.com has engaged Cohen & Company Capital Markets ("CCM"), a division of J.V.B. Financial Group, LLC, as its financial advisor to help oversee and structure its acquisition strategy. The Company’s “buy and build” strategy is backed by the United Capital Investments Limited (“UCIL”) $150 million loan facility with support from strategic investors, such as Prosperity Investment Management.

(All dollar figures are in US dollars unless otherwise indicated)

BOSTON and LONDON, May 13, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today reported financial results and business highlights for the first quarter ended March 31, 2024.

Company to host call at 4:30pm today

–Phase 3, HOPE-3 Trial (Cohort A) of CAP-1002 in Duchenne Muscular Dystrophy Fully Enrolled; On Track to Report Top-Line Data in Q4 2024–

- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP)